Literature DB >> 30418790

Ebola: Impact of hospital's admission policy in an overwhelmed scenario.

Mondal Hasan Zahid1, Christopher M Kribs.   

Abstract

Infectious disease outbreaks sometimes overwhelm healthcare facilities. A recent case occurred in West Africa in 2014 when an Ebola virus outbreak overwhelmed facilities in Sierra Leone, Guinea and Liberia. In such scenarios, how many patients can hospitals admit to minimize disease burden? This study considers what type of hospital admission policy during a hypothetical Ebola outbreak can better serve the community, if overcrowding degrades the hospital setting. Our result shows that which policy minimizes loss to the community depends on the initial estimation of the control reproduction number, R₀. When the outbreak grows extremely fast (R₀ ≫ 1) it is better (in terms of total disease burden) to stop admitting patients after reaching the carrying capacity because overcrowding in the hospital makes the hospital setting ineffective at containing infection, but when the outbreak grows only a little faster than the system's ability to contain it (R₀ ≳ 1), it is better to admit patients beyond the carrying capacity because limited overcrowding still reduces infection more in the community. However, when R₀ is no more than a little greater than 1 (for our parameter values, 1.012), both policies result the same because the number of patients never exceeds the maximum capacity.

Entities:  

Keywords:  Ebola ; Overcrowded hospital ; admission policy ; basic reproduction number ; control reproduction number ; mathematical model ; overwhelmed healthcare facility

Mesh:

Year:  2018        PMID: 30418790     DOI: 10.3934/mbe.2018063

Source DB:  PubMed          Journal:  Math Biosci Eng        ISSN: 1547-1063            Impact factor:   2.080


  1 in total

1.  Assessing the hospital surge capacity of the Kenyan health system in the face of the COVID-19 pandemic.

Authors:  Edwine W Barasa; Paul O Ouma; Emelda A Okiro
Journal:  PLoS One       Date:  2020-07-20       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.